Posted On: 06/09/2016 12:18:40 AM
Post# of 273315
Sanguine Corporation (SGUI) 0.0600 $SGUI
Sanguine proposes change in name to New Alliance BioSciences to reflect its broader scope of research and development activities
M2 - Mon Jun 29, 3:36AM CDT
Sanguine Corp (OTC PINK:SGUI) stated on Friday that it plans to change the name to New Alliance BioSciences upon shareholder's approval.
Sanguine Corp. Inc. (OTC PINK: SGUI) Announces Name Change to New Alliance BioSciences
Marketwired - Fri Jun 26, 10:12AM CDT
Sanguine Corp., Inc. (OTC PINK: SGUI) announced today that it has obtained shareholder approval to change the name of the Company to New Alliance BioSciences. Frank Marra, President of the Company, made the following statement, "After careful consideration, and in order to better define our future, we have gotten shareholder approval to change our Company name to New Alliance BioSciences." Mr. Marra added, "The world of oxygen therapeutics has progressed tremendously over the past five years and encompasses exponentially more indications other than just blood substitution and transfusions. We feel that the name Sanguine Corp. no longer reflects the broader scope of our research and development efforts."
Sanguine proposes change in name to New Alliance BioSciences to reflect its broader scope of research and development activities
M2 - Mon Jun 29, 3:36AM CDT
Sanguine Corp (OTC PINK:SGUI) stated on Friday that it plans to change the name to New Alliance BioSciences upon shareholder's approval.
Sanguine Corp. Inc. (OTC PINK: SGUI) Announces Name Change to New Alliance BioSciences
Marketwired - Fri Jun 26, 10:12AM CDT
Sanguine Corp., Inc. (OTC PINK: SGUI) announced today that it has obtained shareholder approval to change the name of the Company to New Alliance BioSciences. Frank Marra, President of the Company, made the following statement, "After careful consideration, and in order to better define our future, we have gotten shareholder approval to change our Company name to New Alliance BioSciences." Mr. Marra added, "The world of oxygen therapeutics has progressed tremendously over the past five years and encompasses exponentially more indications other than just blood substitution and transfusions. We feel that the name Sanguine Corp. no longer reflects the broader scope of our research and development efforts."
(0)
(0)
